# Identification and Functional Characterization of a Novel SEMA3A Exon Deletion Variant in Kallmann Syndrome

**Authors:** Shaolian Zang, Shasha Zhou, Qingxu Liu, Xiaoqin Yin, Pin Li

PMC · DOI: 10.1002/mgg3.70190 · Molecular Genetics & Genomic Medicine · 2026-01-14

## TL;DR

A new SEMA3A gene variant linked to Kallmann syndrome was found to disrupt GnRH neuron migration and affect cell and gonad development.

## Contribution

A novel SEMA3A exon deletion variant in Kallmann syndrome is identified and functionally characterized for the first time.

## Key findings

- The SEMA3A exon 6–9 deletion variant reduces protein expression and inhibits GnRH neuronal migration.
- RNA sequencing shows altered gene expression in cell migration, gonad development, and synaptic pathways.
- The SEMA3A mutation expands the known mutation spectrum of Kallmann syndrome.

## Abstract

Kallmann syndrome (KS) is a genetic disorder characterized by impaired reproductive system and olfactory development. This study aimed to identify a novel variant of SEMA3A in a KS patient and explore its potential pathogenic mechanism.

A gene panel was used to identify potential pathogenic mutations. Wild‐type and mutant SEMA3A overexpression plasmids were constructed. Western blotting, RNA sequencing, and cell migration were performed to assess the effects of SEMA3A gene variations on GnRH neuronal migration.

A novel heterozygous mutation in the SEMA3A gene (NM_006080.3: exon 6–9 deletion) was identified in the proband, as well as in his father and sister. The spatial structure of the SEMA3A mutant protein was relatively looser. In vitro experiments revealed that SEMA3A mutation reduced SEMA3A expression and inhibited GnRH neuronal migration. RNAseq analysis revealed that the expression of 76 genes was upregulated and that of 104 genes was downregulated after SEMA3A mutation. The altered gene clusters were enriched mainly in cell migration, male gonad development, motor proteins, and neuron synapses.

In this study, we identified a novel variant of SEMA3A in a KS patient and verified its function. These findings expand the mutation spectrum of the SEMA3A gene and offer a theoretical basis for the clinical diagnosis of KS.

The study identified a novel SEMA3A exons 6–9 deletion variant in Kallmann syndrome that impairs GnRH neuronal migration and alters cell migration, gonad development, and synaptic pathways. The study expands mutation spectrum and offers mechanistic insights for clinical diagnosis of Kallmann syndrome.

## Linked entities

- **Genes:** SEMA3A (semaphorin 3A) [NCBI Gene 10371]
- **Proteins:** SEMA3A (semaphorin 3A)
- **Diseases:** Kallmann syndrome (MONDO:0018800)

## Full-text entities

- **Genes:** SEMA3A (semaphorin 3A) [NCBI Gene 10371] {aka COLL1, HH16, Hsema-I, Hsema-III, SEMA1, SEMAD}, GNRH1 (gonadotropin releasing hormone 1) [NCBI Gene 2796] {aka GNRH, GRH, LHRH, LNRH}
- **Diseases:** KS (MESH:D017436), genetic disorder (MESH:D030342)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12800911/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12800911/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12800911/full.md

---
Source: https://tomesphere.com/paper/PMC12800911